Pacific Biosciences of California (PACB) Financial Statements & Analysis

Pacific Biosciences of California (PACB) Income Statement

Pacific Biosciences of California reported revenue of $160.00M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 3.9% from $154.01M a year earlier. Pacific Biosciences of California posted a net loss of $546.38M, compared with a net loss of $309.85M a year earlier. Gross margin was 31.7% and operating margin -348.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $39.01M, down 1.9% from the same quarter a year earlier.

Pacific Biosciences of California Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Pacific Biosciences of California, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	160.01	154.01	200.52	128.30	130.51	78.89	90.89	78.63	93.47
Cost of Revenue	109.33	116.73	147.74	79.27	71.35	46.33	56.32	53.53	58.81
Gross Profit	50.67	37.28	52.78	49.04	59.17	32.57	34.58	25.10	34.66
Operating Expenses
Research & Development	97.31	134.92	187.17	193.00	112.90	64.15	59.63	62.59	65.32
Selling, General & Administrative	141.49	175.02	169.82	160.85	124.12	72.80	75.49	63.49	59.12
Operating Expenses	608.24	511.60	387.25	356.23	269.60	136.95	135.12	126.08	124.44
Operating Income	-557.56	-474.31	-334.47	-307.20	-210.44	-104.39	-100.55	-100.99	-89.78
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.09	0.00	0.00	0.00	0.00
Interest Expense	6.95	13.41	14.34	14.69	-12.53	0.27	2.61	2.42	2.92
Other Income/Expense	11.50	164.78	16.31	-7.05	-64.44	133.79	16.41	-1.58	-2.41
Income
Income Before Tax	-546.06	-309.54	-318.16	-314.25	-274.87	29.40	-84.13	-102.56	-92.19
Income Tax Expense	0.32	0.32	-11.42	0.00	-93.65	0.00	0.00	0.85	0.00
Net Income	-546.38	-309.85	-306.74	-314.25	-181.22	29.40	-84.13	-102.56	-92.19
Net Income - Continuous Operations	-546.38	-309.85	-306.74	-314.25	-181.22	29.40	-84.13	-102.56	-92.19
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	-34.20	-242.77	-271.13	-282.24	-170.58	38.97	-71.58	-92.92	-80.83
EBIT	-539.10	-296.12	-303.82	-304.82	-178.16	-63.70	-	-	-
Depreciation & Amortization	504.91	53.35	32.69	17.32	7.58	9.30	9.95	7.22	8.44
Earnings Per Share
Basic EPS	-2.00	-1.00	-1.00	-1.00	-1.00	-	-1.00	-1.00	-1.00
Diluted EPS	-2.00	-1.00	-1.00	-1.00	-1.00	-	-1.00	-1.00	-1.00
Basic Shares Outstanding	299.96	274.49	253.63	224.55	204.14	165.19	152.53	134.95	105.68
Diluted Shares Outstanding	299.96	288.37	253.63	224.55	204.14	174.97	152.53	135.09	105.68

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pacific Biosciences of California Financial Statements

What was Pacific Biosciences of California's revenue in fiscal 2025?

Pacific Biosciences of California reported revenue of $160.00M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 3.9% from $154.01M a year earlier.

Is Pacific Biosciences of California profitable?

No. Pacific Biosciences of California reported a net loss of $546.38M in fiscal 2025. In fiscal 2024 it lost $309.85M.

What is Pacific Biosciences of California's operating margin?

Pacific Biosciences of California's operating income was −$557.56M on revenue of $160.00M in fiscal 2025, an operating margin of -348.5%, compared with -308.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition